*September 2020*
What are new treatment options for EGFR lung cancer patients? In this segment from our recent Lung Cancer Answers Now program, two lung cancer experts, Dr. Bruce Johnson from Dana-Farber Cancer Institute and Dr. Alex Spira from Virginia Cancer Specialists explain two studies that provide new treatment options for EGFR lung cancer patients. They also discuss the difference between progression free and disease free survival. This is segment 1 of a 4 part program.
Part 1 NCSLC EGFR Mutation Treatment
Part 2 What is the First Line Treatment for EGFR-Mutant NSCLC?
Part 3 Managing EGFR Inhibitor Side Effects
Part 4 Clinical Trials For EGFR Lung Cancer
